Campus Construction Update

Starting September 14, we’re closing the Menino building lobby entrance. This, along with the ongoing Yawkey building entrance closure, will help us bring you an even better campus experience that matches the exceptional care you've come to expect. Please enter the Menino and Yawkey buildings through the Moakley building, and make sure to leave extra time to get to your appointment. Thank you for your patience. 

Click here to learn more about our campus redesign. 

About

Salant is Professor of Medicine and Vice-Chair for Research. He received his medical degree from University of the Witwatersrand in South Africa and completed his clinical training at the Johannesburg Hospital. He received his research training at Boston University with Dr. William G. Couser and joined BU’s nephrology faculty in 1979. Dr. Salant is an internationally renowned physician-scientist and an acclaimed educator. His research primarily explores the immune basis for glomerular diseases and the mechanisms of podocyte injury. He was among the first to identify podocytes as the primary target of injury in antibody-mediated glomerular diseases. In a landmark New England Journal of Medicine paper in 2009, Drs. Salant, Beck and colleagues described their discovery of the target antigen in membranous nephropathy and showed that a high proportion of MN patients have circulating autoantibodies to the antigen on human podocytes. Dr. Salant is a past chairman of the ABIM Nephrology Board.
  • Administrative Title

    Vice Chair for Research, Professor of Pathology and Laboratory Medicine, Boston University Chobanian and Avedisian School of Medicine

  • Residency

    Johannesburg Hospital, 1970-1974
  • Fellowship

    Boston University School of Medicine (Research) 1977-1979
  • Education

    University of Witwatersrand, South Africa, 1969

Affiliations

Affiliations